Custom Enterprise Software for Pharma & Life Sciences
GxP-validated custom software solutions — MES, EBR, LIMS, QMS, clinical systems — built with AI-accelerated development that cuts timelines by 60-80% while ensuring FDA 21 CFR Part 11 compliance.
Why Custom Pharma Software Now?
AI has permanently changed the economics of enterprise software. Custom systems that once required multi-million-dollar budgets are now accessible to any pharmaceutical company.
60–80%
Cost Reduction
AI-assisted development cuts coding time for regulatory boilerplate — audit trails, e-signatures, RBAC — making enterprise custom software viable for mid-size pharma and biotech for the first time.
8–12 wks
Delivery Timeline
Custom pharmaceutical systems that once required 18-month timelines now deploy in 8–12 weeks. Validation rigor is unchanged — only development speed improves.
Day 1
Compliance by Design
21 CFR Part 11, GAMP 5, and ALCOA+ data integrity built into every system from the first line of code — not retrofitted after development is complete.
$0
Platform Tax Eliminated
Stop paying six-figure annual licensing fees for commercial platforms that cover 70% of your needs. Custom systems eliminate the workarounds and gap analysis required by off-the-shelf tools.
Why Custom Software Now?
AI has created a unique window of opportunity for pharmaceutical companies to build competitive advantages through purpose-built enterprise software.
Related topics
Cost RevolutionSpeed AdvantageCompliance ReadyProcess Automation
- 60-80% Cost Reduction: AI-assisted development dramatically reduces coding time for boilerplate regulatory infrastructure — audit trails, electronic signatures, role-based access, validation documentation — making custom solutions viable where they never were before.
- 3-5x Faster Delivery: What traditionally took 12-18 months now takes 8-12 weeks with AI-powered rapid prototyping and automated code generation. Validation and testing timelines remain appropriately rigorous.
- 100% Compliance by Design: Built-in FDA, GxP, and 21 CFR Part 11 compliance from the first line of code, not retrofitted after development.
- 90% Less Manual Work: Complex processes that were too expensive to automate — deviation investigations, batch record reviews, stability trending — are now prime candidates for intelligent automation.
- Eliminate Platform Tax: Stop paying six-figure annual licensing fees for commercial platforms that cover 70% of your needs and force workarounds for the rest.
- Regulatory Preparedness: Stay ahead of evolving FDA guidance on Computer Software Assurance and the shift toward risk-based validation approaches.
Pharmaceutical Inventory, Serialization & DSCSA Compliance
The Drug Supply Chain Security Act (DSCSA) requires end-to-end serialization at the unit level in GS1 EPCIS format. Our custom inventory systems handle serial number generation, aggregation hierarchies, IoT cold chain monitoring, DEA controlled substance compliance, FEFO allocation, quarantine management workflows, and bidirectional WMS integration — natively, without the bolted-on modules general-purpose platforms require.
Electronic Batch Records & Manufacturing Execution Systems
EBR systems eliminate paper batch records by capturing critical process parameters in real time — material additions, operator signatures, equipment status, environmental conditions — and presenting review-by-exception dashboards that reduce batch review time by 70–90%. Our MES solutions bridge ERP and shop floor per ISA-95, manage master recipes per ISA-88, enforce process sequence, and maintain 21 CFR Part 11 audit trails.
Laboratory Information Systems & Scientific Data Management
Custom LIMS extensions add stability study management per ICH Q1A–Q1E, automated OOS investigation workflows per FDA guidance, and direct instrument integration (HPLC, GC, dissolution, Karl Fischer) eliminating manual transcription errors. Scientific Data Management Systems archive raw data with cryptographic integrity verification, satisfying ALCOA+ principles — Attributable, Legible, Contemporaneous, Original, and Accurate — across the full laboratory data lifecycle.
Quality Management Systems: CAPA, Deviations & Change Control
Custom QMS platforms are built around your workflows per ICH Q10. CAPA modules implement the full lifecycle from root cause analysis (Ishikawa, 5-Whys) through effectiveness checks. Deviation management applies ICH Q9 risk-based investigation routing; change control manages NDA supplement vs. annual report filing assessment; complaint handling enforces 21 CFR 314.80 adverse event reporting timelines.
Core Development Capabilities
End-to-end custom software solutions across the pharmaceutical value chain.
Research & Clinical
Compound library management, ELN, bioinformatics pipelines, EDC/eCRF, CTMS, RTSM/IRT, ePRO/eCOA, safety databases, TMF.
Learn moreRegulatory & Compliance
Submission management, regulatory intelligence, audit trail, 21 CFR Part 11, GAMP 5 validation, change control.
Learn moreQuality Management
Digital QMS with CAPA, deviation management, change control, complaint handling, supplier qualification, audit management.
Learn moreCommercial Operations
HCP engagement platforms, market access tools, patient support programs, omnichannel marketing.
Learn moreManufacturing & Supply
MES, EBR, real-time process monitoring, recipe management, serialization, inventory and warehouse management.
Learn moreData & Analytics
Real-world evidence platforms, predictive analytics, AI/ML pipelines, regulatory intelligence, SDMS.
Learn moreEDC, CTMS & Risk-Based Monitoring
Custom EDC extensions add intelligent edit checks for complex eligibility criteria, automated MedDRA and WHO Drug coding, and real-time quality scoring dashboards. CTMS integration synchronizes enrollment, monitoring visits, and milestones across EDC, RTSM, and TMF systems. Unified operational analytics generate Key Risk Indicators and Quality Tolerance Limits per ICH E6(R2) for risk-based monitoring.
RTSM/IRT & Investigational Drug Supply
Custom RTSM solutions handle adaptive randomization algorithms, multi-factor stratification, dose escalation logic, and global depot inventory optimization that minimizes IMP waste while preventing site stockouts. Integration with clinical supply chain systems manages temperature-controlled drug distribution, return and destruction reconciliation, and real-time supply forecasting based on enrollment projections and protocol amendment scenarios.
Safety Databases & Trial Master File Management
Safety database integrations ensure serious adverse events flow automatically from EDC to Oracle Argus or Veeva Vault Safety with all required fields mapped, eliminating manual reconciliation that delays 15-day IND safety reports per 21 CFR 312.32. TMF solutions automate document collection against ICH E6 milestones, track completeness by zone and artifact against the TMF Reference Model, and generate inspection readiness scores.
Cloud Architecture & Technical Delivery
Purpose-built pharmaceutical cloud infrastructure with validated deployment pipelines, automated testing, and documented change control. We leverage AWS GxP and Azure Life Sciences frameworks, define all infrastructure as code with Terraform, and orchestrate complex workflows via Temporal.io for exactly-once execution guarantees in GxP processes.
Schedule a Technical ReviewGxP-Validated Cloud Infrastructure
AWS GxP and Azure Life Sciences frameworks with IQ/OQ/PQ qualification protocols, Terraform IaC, multi-AZ deployment, and SOC 2 controls.
CI/CD with Regulatory Change Control
Gated pipelines with automated regression testing, electronic approval workflows, and full evidence packages per FDA CSA guidance.
Disaster Recovery & Business Continuity
Tested RPO/RTO targets, automated failover, quarterly DR exercises, and documented backup restoration meeting EU Annex 11 requirements.
Our AI-Accelerated Development Process
From concept to validated deployment in 8-12 weeks, not 12-18 months.
01
Discovery & Compliance Mapping
Analyze processes, identify automation opportunities, map regulatory requirements, define URS, and classify system functions by GxP risk per GAMP 5 methodology. Timeline: 1-2 weeks.
02
AI-Powered Prototyping
Create functional prototypes in days using AI tools, enabling early validation and user feedback. Generate functional and design specifications with full requirements traceability. Timeline: 2-3 weeks.
03
Iterative Development & Validation
Continuous development with built-in validation protocols, automated testing at every level, IQ/OQ/PQ execution, and traceability matrix maintenance. Timeline: 4-8 weeks.
04
Deployment, Training & Lifecycle Handoff
Seamless deployment with comprehensive validation summary report, user training, administrator training, SOPs, and transition to lifecycle support with defined SLAs. Timeline: 1-2 weeks.
GAMP 5 Risk-Based Testing & Validation
Our V-model testing maps to GAMP 5 risk categories: unit tests in CI, integration tests across system boundaries, system testing in qualified environments, and UAT with quality-approved scenarios. Automated suites generate full evidence packages — test scripts, execution logs, pass/fail results, screenshots — satisfying FDA Computer Software Assurance expectations for risk-based testing.
Security Testing & OWASP Compliance
Security testing covers SAST in CI, DAST against deployed applications, and manual penetration testing before production deployment. We test against OWASP Top 10 vulnerabilities and, for systems handling patient data, HIPAA safeguards including access controls, audit logging, and breach notification mechanisms. Security test findings are tracked through the CAPA system with documented remediation evidence in the validation package.
Post-Deployment Lifecycle Management
Maintaining a validated state requires ongoing change control, patch management, and periodic review. Our patch process classifies by CVSS severity — critical patches within 72 hours, high within 14 days — with automated regression testing on every deployment. Annual periodic reviews per EU Annex 11 and GAMP 5 assess cumulative change impact and confirm the system remains fit for intended use.
Built-In Compliance & Security
Every system we deliver is designed to meet global pharmaceutical regulatory standards from the first line of code.
21 CFR Part 11 Electronic Signatures
Biometric or password-based e-signatures with complete audit trails for all GxP transactions, meeting FDA electronic records requirements.
GAMP 5 Validation Methodology
Risk-based validation per ISPE GAMP 5 Second Edition with full IQ/OQ/PQ documentation, traceability matrices, and validation summary reports.
ALCOA+ Data Integrity
Attributable, Legible, Contemporaneous, Original, and Accurate data with Complete, Consistent, Enduring, and Available safeguards throughout the data lifecycle.
HIPAA & NIST Cybersecurity
HIPAA-ready architecture, NIST Cybersecurity Framework alignment, AES-256 encryption, MFA, and IEC 62443 for OT environments with SOC 2 controls.
EU Annex 11 & ISO Standards
Compliance with EU Annex 11 computerized systems requirements, ISO 13485 quality management, ISO 14971 risk management, and IEC 62304 software lifecycle.
Change Control & Audit Trails
Tamper-proof, timestamped audit trails for every system action. Full change control integration with impact assessment, approval workflow, and regulatory filing assessment.
Modern Technology Stack
Cutting-edge AI and cloud technologies for pharmaceutical-grade, GxP-validated solutions.
AI & Machine Learning
GPT-4, Claude, TensorFlow, PyTorch, AutoML platforms, computer vision, and NLP for pharmaceutical text analysis and document processing.
Cloud Platforms
AWS GxP-compliant infrastructure, Azure Life Sciences, HIPAA-eligible services, and FedRAMP-ready environments for regulated workloads.
Development Stack
React and Next.js frontends, Python and Node.js backends, Temporal.io workflow orchestration, PostgreSQL, and Terraform infrastructure as code.
Integration Partners
Veeva Vault APIs, Salesforce Health Cloud, SAP PI/PO and OData, Oracle EBS, HL7 FHIR R4, Docker and Kubernetes for regulated deployments.
Custom Enterprise Software for Pharma: Frequently Asked Questions
AI-assisted development has reduced coding time by 60-80%, making custom enterprise solutions financially viable for mid-size pharmaceutical and biotech companies. What once required multi-million-dollar budgets and 18-month timelines can now be delivered in 8-12 weeks at a fraction of the cost. This is particularly impactful for regulated systems where boilerplate code for audit trails, electronic signatures, and role-based access control can be generated and validated rapidly. The cost reduction applies to the development phase; validation, testing, and regulatory documentation still require the same rigor as traditional projects, ensuring quality is never compromised.
We build a comprehensive range of GxP-validated enterprise systems spanning the pharmaceutical value chain. This includes manufacturing execution systems (MES), electronic batch record systems, laboratory information management systems (LIMS), quality management systems (QMS), clinical trial management systems (CTMS), regulatory submission platforms, inventory and warehouse management systems, and data analytics platforms. Each system is built with 21 CFR Part 11 compliance from day one and integrates with existing enterprise infrastructure including SAP, Oracle, and Veeva systems.
All our solutions are built with compliance as a foundational design principle, not an afterthought. We follow ISPE GAMP 5 risk-based validation methodology, implement 21 CFR Part 11 electronic signatures and audit trails, and adhere to ALCOA+ data integrity principles as defined in FDA and EU Annex 11 guidance. We generate complete validation documentation packages including User Requirements Specifications, Functional Specifications, Design Specifications, IQ/OQ/PQ protocols, traceability matrices, and summary reports. Our approach aligns with the FDA Computer Software Assurance guidance for risk-based testing.
Off-the-shelf QMS platforms like Veeva Quality, MasterControl, and Trackwise offer broad functionality but often require extensive configuration, expensive licensing, and compromises in workflow design. Custom QMS solutions are built precisely around your quality processes, organizational structure, and regulatory requirements. Custom systems eliminate the gap analysis and workaround documentation that commercial platforms require, and they can integrate natively with your existing MES, LIMS, and ERP systems without middleware. For organizations with unique quality workflows or those operating across multiple regulatory jurisdictions, custom QMS development often delivers lower total cost of ownership over a five-year horizon while providing superior user adoption and process compliance.
Cloud validation follows the same GAMP 5 principles as on-premise systems, with additional considerations for infrastructure qualification. We leverage AWS GxP-compliant infrastructure and Azure Life Sciences compliance frameworks, which provide pre-qualified infrastructure components. The cloud service provider is responsible for infrastructure qualification (IaaS layer), while we validate the application layer through IQ/OQ/PQ protocols. We use Infrastructure as Code with Terraform to ensure reproducible, auditable deployments, and our CI/CD pipelines include automated regression testing to maintain the validated state across updates.
Data migration in regulated environments requires meticulous planning to maintain data integrity and regulatory compliance. Our approach begins with a comprehensive data mapping exercise that identifies all source data elements, transformation rules, and target schema requirements. We build automated migration scripts with built-in reconciliation checks that verify record counts, checksums, and referential integrity at every stage. All migration activities are documented in a formal Migration Validation Protocol that satisfies FDA and EMA data integrity expectations. We perform trial migrations in a qualified staging environment before executing the final production migration, and we maintain the legacy system in read-only mode for a defined parallel operation period to ensure business continuity.
GAMP 5 Category 5 custom applications require the most rigorous testing strategy because the software is built specifically for the regulated process and cannot rely on vendor-provided validation evidence. Our testing approach follows a V-model aligned with GAMP 5 Second Edition risk-based principles. We implement unit testing at the code level, integration testing across system boundaries, system testing against functional specifications, and user acceptance testing against user requirements. For GxP-critical functions, we apply additional verification including boundary analysis, negative testing, and stress testing. Our test automation frameworks generate evidence packages that satisfy regulatory auditors, including test scripts, execution logs, screenshots, and defect resolution documentation.
Integration with enterprise platforms is a core competency. We have deep experience with Veeva Vault APIs, Vault CRM data models, and Veeva Network integrations. For SAP integration, we work with SAP PI/PO middleware, RFC/BAPI interfaces, and OData services to connect custom systems with SAP ERP, SAP QM, and SAP PP modules. Oracle integration covers Oracle EBS, Oracle Manufacturing, and Oracle LIMS through REST APIs and database-level connectivity. All integrations include error handling, retry logic, audit logging, and data reconciliation to ensure no transactions are lost in transit between systems.
Our solutions implement defense-in-depth security aligned with the NIST Cybersecurity Framework and OWASP Top 10 remediation. This includes encryption at rest and in transit (AES-256, TLS 1.3), multi-factor authentication, role-based access control with segregation of duties, session management, input validation, parameterized queries to prevent injection attacks, and comprehensive security logging. For manufacturing and operational technology environments, we follow IEC 62443 industrial cybersecurity standards. All systems undergo penetration testing before deployment, and we provide ongoing vulnerability scanning and patch management as part of our lifecycle support services.
Post-deployment change management is critical to maintaining the validated state of any GxP system. We implement a formal change control process that classifies every change by risk impact: cosmetic changes undergo abbreviated testing, functional changes require targeted regression testing, and GxP-critical changes trigger full revalidation of affected functions. Our CI/CD pipeline enforces this through automated classification, gated deployments, and mandatory approval workflows that mirror your change advisory board process. All changes are documented with a change request, impact assessment, test evidence, and approval records that form a complete regulatory audit trail. We also conduct periodic system reviews to assess cumulative change impact and determine whether a full periodic revalidation is warranted.
Ready to Transform Your Pharmaceutical Operations with Custom Software?
Join leading pharmaceutical and biotech companies leveraging AI-accelerated development to build purpose-built enterprise systems. Start with a free consultation and compliance assessment.
Schedule Free Consultation